How big is the Global Heparin Market?

The Global Heparin Market size is expected to reach USD 9.37 billion in 2024 and grow at a CAGR of 7.12% to reach USD 13.23 billion by 2029. Read More

What is the current Global Heparin Market size?

In 2024, the Global Heparin Market size is expected to reach USD 9.37 billion. Read More

Who are the key players in Global Heparin Market?

Opocrin SpA, Baxter International, Aspen Pharmacare Holdings Limited, B Braun Melsungen AG and Pfizer Inc. are the major companies operating in the Global Heparin Market. Read More

Which is the fastest growing region in Global Heparin Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Heparin Market?

In 2024, the North America accounts for the largest market share in Global Heparin Market. Read More

What years does this Global Heparin Market cover, and what was the market size in 2023?

In 2023, the Global Heparin Market size was estimated at USD 8.75 billion. The report covers the Global Heparin Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Heparin Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Heparin Market Share

Statistics for the 2023 & 2024 Global Heparin market share, created by Mordor Intelligence™ Industry Reports. Global Heparin share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Heparin Industry

The heparin market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. Some of the key companies include Aspen Pharmacare Holdings Limited, B Braun Melsungen AG, Baxter International Inc., Dr. Reddy's Laboratories, Hebei Changshan Biochemical Pharmaceutical, Leo Pharma AS, Opocrin SpA, Pfizer Inc, FRESENIUS KABI, GLAND PHARMA, HIKMA PHARMACEUTICALS, Techdow USA, Viatris Inc., Novartis AG, and Smiths Medical among others.